Form 4: Organon & Co. Executive Reports Changes in Beneficial Ownership
SEC Form 4
Juan Camilo Arjona Ferreira, Head of R&D & CMO at Organon & Co., reports transactions involving common stock and restricted stock units.
Summary
- On November 7, 2024, Juan Camilo Arjona Ferreira, Head of R&D & CMO at Organon & Co., filed a Form 4 to report changes in beneficial ownership.
- The transactions involved common stock and restricted stock units (RSUs).
- 6,446 shares of common stock were acquired upon the vesting of RSUs.
- 2,300 shares were disposed of to cover tax obligations at a price of $15.8 per share.
- Following these transactions, Ferreira directly owns 11,687.355 shares of common stock.
- Ferreira also directly owns 12,893 restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing reflecting standard executive compensation practices; it doesn't inherently indicate positive or negative sentiment.
Industry Context
This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock.
Key Dates
| Date | Description |
|---|---|
| 11/07/2024 | Date of transaction and RSU vesting. |
| 11/07/2025 | Next RSU vesting installment date. |
| 11/07/2026 | Final RSU vesting installment date. |
| 11/08/2024 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.